<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/'><id>tag:blogger.com,1999:blog-28450497.post9052367300637637188..comments</id><updated>2008-12-10T01:42:24.686-05:00</updated><category term='Channel Management'/><category term='Supply Chain Technology'/><category term='Blog Administration'/><category term='Importation'/><category term='Health Care Policy'/><category term='Group Purchasing Organizations (GPOs)'/><category term='Drug Shortages'/><category term='Industry Trends'/><category term='Fun Stuff'/><category term='PBMs'/><category term='Wholesalers'/><category term='Pharmacy Economics'/><category term='Pharmacy'/><category term='Supply Chain Humor'/><category term='Drug Counterfeiting'/><category term='Health Care Reform'/><category term='Pharmacogenomics'/><category term='Pedigree'/><category term='Specialty Drugs'/><category term='Medicare Part D'/><category term='Average Sales Price (ASP)'/><category term='Accountable Care Organizations (ACOs)'/><category term='Generic Drugs'/><category term='Guest Post'/><category term='Marketing'/><category term='RFID'/><category term='Average Acquisition Cost (AAC)'/><category term='International Drug Channels'/><category term='Enforcement'/><category term='Costs/Reimbursement'/><category term='Average Manufacturer Price (AMP)'/><category term='Mergers and Acquisitions'/><title type='text'>Comments on Drug Channels: New York Times editors read this blog!</title><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://www.drugchannels.net/feeds/9052367300637637188/comments/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/9052367300637637188/comments/default'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2006/11/new-york-times-editors-read-this-blog.html'/><author><name>Adam J. Fein, Ph.D.</name><uri>http://www.blogger.com/profile/12217252282643255442</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='25' height='32' src='http://4.bp.blogspot.com/_jauTfEtde80/TTnq9WCPzYI/AAAAAAAAAAM/VNKwcn8y_BA/s220/AdamJFein-DrugChannels.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>3</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-28450497.post-2426602528941232588</id><published>2006-11-16T18:51:00.000-05:00</published><updated>2006-11-16T18:51:00.000-05:00</updated><title type='text'>The Feds already have a program in place to delive...</title><content type='html'>The Feds already have a program in place to deliver prescription drugs at a very low negotiated price (in most cases their cost is well below what any medicaid program is paying) to members--it's run through the Veterans Administration and is currently only available to current and past members of the armed services and their families.  An expeditious move for the Feds would be to open this program to Medicare Part D "customers".&lt;br /&gt;&lt;br /&gt;Now, the formulary is pretty restrictive and most of the service is delivered by mail, but if you live near a military base and you don't mind the limited hours of availability and your physician is cooperative about using the drugs on the VA formulary, it may be the program for you, AND the Fed gov't wouldn't have to reinvent the wheel to start a brand new program to compete with the private sector--just use the one that's already there.&lt;br /&gt;&lt;br /&gt;Like that'll happen.&lt;br /&gt;&lt;br /&gt;Tom Connelly, RPh</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/9052367300637637188/comments/default/2426602528941232588'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/9052367300637637188/comments/default/2426602528941232588'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2006/11/new-york-times-editors-read-this-blog.html?showComment=1163721060000#c2426602528941232588' title=''/><author><name>Tom Connelly, RPh</name><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img1.blogblog.com/img/blank.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2006/11/new-york-times-editors-read-this-blog.html' ref='tag:blogger.com,1999:blog-28450497.post-9052367300637637188' source='http://www.blogger.com/feeds/28450497/posts/default/9052367300637637188' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-773669452'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-477325673985297503</id><published>2006-11-15T20:30:00.000-05:00</published><updated>2006-11-15T20:30:00.000-05:00</updated><title type='text'>I guess Kaiser reads this blog, too!

But seriousl...</title><content type='html'>I guess Kaiser reads this blog, too!&lt;br /&gt;&lt;br /&gt;But seriously, I recognize that others may have had similar ideas.  I was just surprised to read the NYT because I had not seen the idea in print before I wrote up the blog entry.</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/9052367300637637188/comments/default/477325673985297503'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/9052367300637637188/comments/default/477325673985297503'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2006/11/new-york-times-editors-read-this-blog.html?showComment=1163640600000#c477325673985297503' title=''/><author><name>Adam J. Fein</name><uri>http://www.blogger.com/profile/15774296048321605590</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='26' height='32' src='http://www.naw.org/Images/intro/fein.jpg'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2006/11/new-york-times-editors-read-this-blog.html' ref='tag:blogger.com,1999:blog-28450497.post-9052367300637637188' source='http://www.blogger.com/feeds/28450497/posts/default/9052367300637637188' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-1955505852'/></entry><entry><id>tag:blogger.com,1999:blog-28450497.post-1786781808251185242</id><published>2006-11-15T17:52:00.000-05:00</published><updated>2006-11-15T17:52:00.000-05:00</updated><title type='text'>This option was also mentioned on the KFF web pres...</title><content type='html'>This option was also mentioned on the KFF web presentation on Tuesday.    &lt;br /&gt;&lt;br /&gt;Ask the Experts: Open Enrollment for Medicare Part D 11/14/2006&lt;br /&gt;Kaiser Family Foundation Broadcast Studio, Washington, D.C&lt;br /&gt;&lt;br /&gt;See  http://tinyurl.com/y75suy&lt;br /&gt;&lt;br /&gt;(link was aliased to fit in this window)</content><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/9052367300637637188/comments/default/1786781808251185242'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/28450497/9052367300637637188/comments/default/1786781808251185242'/><link rel='alternate' type='text/html' href='http://www.drugchannels.net/2006/11/new-york-times-editors-read-this-blog.html?showComment=1163631120000#c1786781808251185242' title=''/><author><name>C lbs</name><uri>http://www.blogger.com/profile/14398758870212245527</uri><email>noreply@blogger.com</email><gd:image xmlns:gd='http://schemas.google.com/g/2005' rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:in-reply-to xmlns:thr='http://purl.org/syndication/thread/1.0' href='http://www.drugchannels.net/2006/11/new-york-times-editors-read-this-blog.html' ref='tag:blogger.com,1999:blog-28450497.post-9052367300637637188' source='http://www.blogger.com/feeds/28450497/posts/default/9052367300637637188' type='text/html'/><gd:extendedProperty xmlns:gd='http://schemas.google.com/g/2005' name='blogger.itemClass' value='pid-1614856027'/></entry></feed>
